Inhibikase Therapeutics
IKT
IKT
31 hedge funds and large institutions have $163M invested in Inhibikase Therapeutics in 2024 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 7 increasing their positions, 0 reducing their positions, and 3 closing their positions.
Holders
31
Holders Change
+20
Holders Change %
+181.82%
% of All Funds
0.41%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
23
Increased
7
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
AC
1
Armistice Capital
New York
|
$0 |
2 |
2
Renaissance Technologies
New York
|
$0 |
3 |
TRCT
3
Tower Research Capital (TRC)
New York
|
$0 |